Neurogene Inc.
NGNE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $402 | $249 | $131 | $5,306 |
| - Cash | $137 | $148 | $82 | $71 |
| + Debt | $12 | $16 | $249 | $6 |
| Enterprise Value | $277 | $117 | $298 | $5,242 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2 | -$3 | -$3 | -$42 |
| % Margin | -251% | – | – | – |
| EBITDA | -$72 | -$52 | -$52 | -$50 |
| % Margin | -7,771.4% | – | – | – |
| Net Income | -$75 | -$36 | -$55 | -$51 |
| % Margin | -8,123.7% | – | – | – |
| EPS Diluted | -4.28 | -2.83 | -4.3 | -0.92 |
| % Growth | -51.2% | 34.2% | -367.4% | – |
| Operating Cash Flow | -$71 | -$51 | -$53 | -$46 |
| Capital Expenditures | -$1 | -$0 | -$2 | -$18 |
| Free Cash Flow | -$71 | -$52 | -$55 | -$65 |